Searchable abstracts of presentations at key conferences in endocrinology

ea0014p306 | (1) | ECE2007

Radioactive iodine in the treatment of type 2 amiodarone-induced thyrotoxicosis

Gursoy Alptekin , Bascil Tutuncu Neslihan , Gencoglu Arzu , Yilmaz Hamiyet , Nar Demirer Asli , Guvener Demirag Nilgun

Objective: Amiodarone-induced thyrotoxicosis (AIT) is usually classified into 2 types (type 1, in which a high iodine content triggers the autonomous production of thyroid hormone; and type 2, in which destructive thyroiditis causes the release of preformed thyroid hormone). A mixed form of AIT has also been also described. AIT is a difficult management problem that sometimes requires ablative thyroid therapy. The use of radioactive iodine (RAI) therapy in patients with type 1...

ea0063gp88 | Thyroid Nodules and Cancer | ECE2019

An analysis of false-positive uptake on radioiodine whole-body scintigraphy

Iyidir Ozlem Turhan , Buyukaşık Pırıl , Mwinyi Adam Rajab , Aktas Ayse , Gencoglu Arzu , Tutuncu Neslihan Bascil

Introduction: Radioiodine can be used for the ablation/treatment and imaging of thyroid cancer. However, radioiodine uptake is not specific for thyroid tissue. Iodine-131 can show physiologic accumulation in several organs as breast, thymus, liver and gastrointestinal tract, or in benign conditions, such as cysts and inflammation, or in a variety of benign and malignant non-thyroidal tumors, which could be mistaken for thyroid cancer or cancer metastasis. Here we aimed to eval...